Newsroom
November 1, 2022
The NIA Interventions Testing Program, including UT Health San Antonio, collaborated with peers in Tennessee and Switzerland. Researchers from the National Institute on Aging (NIA)-funded Interventions Testing Program recently reported the discovery of multiple candidate genes that influence longevity. The three Interventions Testing Program sites – UT Health San Antonio, The University of Michigan […]
October 12, 2022
The NIA Interventions Testing Program, including UT Health San Antonio, collaborated with peers in Tennessee and Switzerland. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Oct. 12, 2022) — Researchers from the National Institute on Aging (NIA)-funded Interventions Testing Program recently reported the discovery of multiple candidate genes that influence longevity. The three Interventions Testing Program […]
April 20, 2022
Thanks to international collaboration, more genetic variations for Alzheimer’s disease are known today than ever before. The list of gene variants recognized for late-onset Alzheimer’s grew from one in 2009 to 40 in 2022. This month, scientists published a list of 75, some of which are considered as prime drug targets. Drug development is underway.
January 24, 2022
Scientists look at the molecular mechanisms behind exercise’s health, anti-aging benefits. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Jan. 24, 2022) – After a 15-month-long COVID-19 stoppage, a landmark National Institutes of Health effort to detail the exact molecular mechanisms that explain exercise’s health and anti-aging benefits is again under way. “We’re very excited […]
December 22, 2021
This vignette about Dr. Sudha Seshadri, professor of neurology and founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, is included in this San Antonio Express-News feature titled “Fascinating locals from 2021: From politicians to pandemic heroes.” Read here
December 17, 2021
Emerging evidence suggests it may be possible to treat Alzheimer’s disease by targeting therapy at senescent cells in the brain.
